Circulating sclerostin in disorders of parathyroid gland function.
about
Bone turnover markers in primary hyperparathyroidism.The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.Mechanisms of Normalisation of Bone Metabolism during Recovery from Hyperthyroidism: Potential Role for Sclerostin and Parathyroid Hormone.Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls.Serum sclerostin increases in healthy adult men during bed rest.Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels.Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levelsHow Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits.Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.Clinical utility of serum sclerostin measurements.Hormonal and systemic regulation of sclerostin.Normocalcaemic hypoparathyroidism: prevalence and effect on bone status in older women. The OPUS study.Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.SOST, an LNGFR target, inhibits the osteogenic differentiation of rat ectomesenchymal stem cells.Sclerostin and DKK1 in Primary Hyperparathyroidism
P2860
Q27692682-BD97AFCE-7F66-4E9C-BB7C-F14E3B65688BQ35860523-C2F76882-67AC-4542-8094-A0F6D25B0374Q36031246-333F4008-22A8-4018-B453-6D7E899E7ABEQ36143916-EFAFF1FC-DE72-4946-9700-9A0952E59E54Q36201481-5D473000-8EB9-4739-8A64-EED337FB4245Q36368980-E3A3C5C9-51F4-4CC5-8478-8CC549618D99Q36510250-BD6BD2A9-1EC6-45B6-BCB4-572A741494FCQ36561855-2D1D84B2-31B3-48D9-ABF2-E23B1F23FA69Q36880655-2AE14FFD-2B9F-46A5-950B-848C213C9B43Q37361795-64E5E3A1-EE2A-4E12-8D8F-0BA203A01742Q37605570-5DD056CD-ED80-446F-A4DD-634792FE9462Q39037907-94E345EE-0323-4A74-8F6B-A256A954247DQ41496981-16E487ED-9C7D-4F72-9D41-DE41A40BA07EQ45268599-1C201543-AA81-420D-BFE0-BEC39CE105D9Q47263016-253C5CAA-E8EC-432F-9371-DFF9AA8C9706Q58903530-D5E4E7A2-D573-40B4-AF6B-F732D518C697
P2860
Circulating sclerostin in disorders of parathyroid gland function.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Circulating sclerostin in disorders of parathyroid gland function.
@ast
Circulating sclerostin in disorders of parathyroid gland function.
@en
type
label
Circulating sclerostin in disorders of parathyroid gland function.
@ast
Circulating sclerostin in disorders of parathyroid gland function.
@en
prefLabel
Circulating sclerostin in disorders of parathyroid gland function.
@ast
Circulating sclerostin in disorders of parathyroid gland function.
@en
P2093
P2860
P356
P1476
Circulating sclerostin in disorders of parathyroid gland function.
@en
P2093
Aline G Costa
Donald J McMahon
James Sliney
Marise Lazaretti-Castro
Mishaela R Rubin
Serge Cremers
Shonni J Silverberg
P2860
P304
P356
10.1210/JC.2011-0566
P407
P577
2011-09-21T00:00:00Z